In Vitro Proliferative Reactions by Lymphocytes from both Responder and “Low” Responder Mice to (T, G)-A—L

  • Joost J. Oppenheim
  • Edna Mozes
  • Michael Sela


The capacity to mount an antibody response to many immunogenic systems is under the control of immune response (Ir) genes which are linked to the major histocompatibility locus (H-2) of the mouse (1). Inbred mice of the H-2b type manifest IgM and IgG antibody responses when immunized with a synthetic antigen such as poly(Tyr, Glul)-polyDLAla—polyLYs ((T, G)-A—L) (2). In contrast, mice of the H-2k or s type are “low” responders that ordinarily produce only low titers of both IgM and IgG antibodies to (T, G)A—L (3). In addition, lymphocytes from sensitized responder mice have specific in vitro secondary proliferative reactions to (T, G)-A—L, whereas lymphocytes from sensitized low responders do not(4).


Proliferative Response Lymph Node Cell Cell Mitogen Lymphoproliferative Response Proliferative Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. Benacerraf and H.O. McDevitt, Science 175:273, 1972.PubMedCrossRefGoogle Scholar
  2. 2.
    H.O. McDevitt and M. Sela, J. Exp. Med. 122:517, 1965.PubMedCrossRefGoogle Scholar
  3. 3.
    H.O. McDevitt, J. Immunol. 100:485, 1968.PubMedGoogle Scholar
  4. 4.
    P. Lonai and H.O. McDevitt, J. Exp. Med. 140:977, 1974.PubMedCrossRefGoogle Scholar
  5. 5.
    M.J. Taussig, E. Mozes and R. Isac, J. Exp. Med. 140:301, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    E. Mozes, R. Isac and M.J. Taussig, J. Exp. Med. 141:793, 1975.CrossRefGoogle Scholar
  7. 7.
    A.J. Munro and M.J. Taussig, Nature (in press) 1975.Google Scholar
  8. 8.
    M.H. Julius, E. Simpson and L.A. Herzenberg, Eur. J. Immunol. 3:645, 1973.PubMedCrossRefGoogle Scholar
  9. 9.
    A.B. Peck, E. Katz-Heber and R.E. Click, Eur. J. Immunol. 3:516, 1973.PubMedCrossRefGoogle Scholar
  10. 10.
    A.B. Peck and F.H. Bach, J. Immunol. Meth. 3:147, 1973.CrossRefGoogle Scholar
  11. 11.
    E. Mozes, R. Isac, D. Givol, R. Zakut and D. Beitsch in these proceedings.Google Scholar
  12. 12.
    J. Green, W.E. Paul and B. Benacerraf, J. Exp. Med. 123:859, 1966.PubMedCrossRefGoogle Scholar
  13. 13.
    J.C. Ordal and F.C. Grumet, J. Exp. Med. 136:1195, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    M.L. Tyan, J. Immunol. 108:65, 1972.PubMedGoogle Scholar
  15. 15.
    K.B. Bechtold, T.G. Wegmann, J.H. Freed, F.C. Grumet, B.W. Chesebro, L.A. Herzenberg and H.O. McDevitt, Cell Immunol. 13: 264, 1974.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Joost J. Oppenheim
    • 1
  • Edna Mozes
    • 1
  • Michael Sela
    • 1
  1. 1.Department of Chemical ImmunologyWeizmann Institute of ScienceRehovotIsrael

Personalised recommendations